KR810001114B1 - Process for preparation of l-alginine by fermentation - Google Patents

Process for preparation of l-alginine by fermentation Download PDF

Info

Publication number
KR810001114B1
KR810001114B1 KR1019800000353A KR800000353A KR810001114B1 KR 810001114 B1 KR810001114 B1 KR 810001114B1 KR 1019800000353 A KR1019800000353 A KR 1019800000353A KR 800000353 A KR800000353 A KR 800000353A KR 810001114 B1 KR810001114 B1 KR 810001114B1
Authority
KR
South Korea
Prior art keywords
arginine
decarboxylase
fermentation
medium
kfcc
Prior art date
Application number
KR1019800000353A
Other languages
Korean (ko)
Inventor
임병학
한상열
이강만
Original Assignee
미원주식회사
홍연석
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미원주식회사, 홍연석 filed Critical 미원주식회사
Priority to KR1019800000353A priority Critical patent/KR810001114B1/en
Application granted granted Critical
Publication of KR810001114B1 publication Critical patent/KR810001114B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/10Citrulline; Arginine; Ornithine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01019Arginine decarboxylase (4.1.1.19)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/84Brevibacterium

Landscapes

  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L-Arginine was prepd. by fermn. Thus, Breribactrium. flavum MS-05760 (KFCC 10018) was inoculated in culture media which contained molasses 5%, NH2Cl 2.5%, peptone 0.1%, yeast ext. 0.1%, K2HPO4 1.0%, MgSO4 0.05%, FeSO4 0.001%, corn steep liquor 1.5%, MnSO4 0.001%, CaCO3 2%, and fermented at 30oC in 65hr. with shaking condition. L-Arginine productivity is 20.8 mg/m in broth.

Description

발효법에 의한 L-알기닌의 제조법Preparation of L-arginine by fermentation

본 발명은 발효법에 의한 L-알기닌의 제조법에 관한 것이다. L-알기닌은 천연아미노산의 일종으로서 영양 및 의약용으로 대단히 중요하며 동시에 최근 조미료 및 사료 등으로 이용되는 중요한 아미노산의 일종이다.The present invention relates to a method for producing L-arginine by the fermentation method. L-arginine is a kind of natural amino acid, which is very important for nutrition and medicine, and at the same time, it is an important amino acid used for seasoning and feed.

과거 L-알기닌의 공업적인 제조방법으로는 천연단백질의 가수분해물로부터 추출 분리하는 방법이었으나 추출분리조직이 대단히 복잡하여 L-알기닌의 제조가는 고가일 수 밖에 없었다.In the past, the industrial production of L-arginine was a method of extracting and separating from hydrolysates of natural proteins. However, the extraction separation structure was very complicated, and thus L-arginine was inexpensive.

그러나 최근에는 발효법에 의한 방법중 주로 L-알기닌 길항체에 내성인 세균 즉, L-알기닌에 의해 제어기구가 해제된 변이주를 사용하여, L-알기닌을 생성시키는 방법이 많이 보고되고 있다.In recent years, however, many methods for producing L-arginine have been reported using fermentation methods, which are mainly resistant to L-arginine antagonists, that is, mutants whose control mechanisms are released by L-arginine.

(일본 특허 48-3391 Agr. Biol Chem 36, 1675-1684(1972))(Japanese Patent 48-3391 Agr. Biol Chem 36, 1675-1684 (1972))

본 발명의 L-알기닌 발효에 사용하는 미생물은 L-알기닌 대사 길항체에 내성을 가져 L-알기닌에 의해 대사조절을 해제시키는 것이 아니고 미생물 자체가 알기닌탈탄산효소·알기닌탈탄산산화효소를 동시에 결손시킴으로써 알기닌 생합성계를 활성화시켜 알기닌의 생산능을 현저하게 개량시키는 데 있다.The microorganism used for the L-arginine fermentation of the present invention is resistant to L-arginine metabolic antagonists and does not release the metabolic regulation by L-arginine, but the microorganism itself deletes arginine decarboxylase and arginine decarboxylase simultaneously. By activating the arginine biosynthesis system, the production capacity of arginine is remarkably improved.

즉, 본 발명자 등은 알기닌탈탄산효소, 알기닌탈탄산산화효소가 알기닌 생합성계의 대사조절에 관여 된다는 것을 착상하여 알기닌탈탄산효소, 알기닌탈탄산산화효소를 동시에 결손시킨 균주를 변이유도 하므로써 알기닌탈탄산화효소, 알기닌탈탄산산화효소에 의한 알기닌 생합성계의 효소 저해가 해제되기 때문에 통상의 탄소원을 함유한 영양배지에서 L-알기닌을 현저하게 많이 생성할 수 있음을 발견하고 본 발명을 완성하였다.In other words, the present inventors have conceived that arginine decarboxylase and arginine decarboxylase are involved in the metabolic regulation of arginine biosynthesis, and thus mutagenesis of alginine decarboxylase and arginine decarboxylase by simultaneously inducing mutations in alginine decarboxylase. The present invention has been completed by discovering that the enzyme inhibition of the arginine biosynthesis system by oxidase and arginine decarboxylase can be released significantly in the nutrient medium containing a common carbon source.

본 발명에 사용된 미생물은 L-알기닌 생산능이 있는 브레비 박테리움푸라붐 ATCC 14067에서 변이유도된 알기닌탈탄산효소, 알기닌탈탄산산화효소를 동시에 결손시킨 변이주 브레비박테티룸푸라붐 MS-05760(KFCC 10018)이다.The microorganism used in the present invention is a mutant Brevibactetilumfura boom MS-05760 (L-arginine-producing brevy bacterium fura boom ATCC 14067, which simultaneously depleted the mutated arginine decarboxylase and arginine decarboxylase). KFCC 10018).

이 결손주는 통상의 변이유도조작으로 예를 들면, X선조사, 자외선조사 또는 화학변이유기체(예를 들면 N-메틸-N'-N 니트로소구아니딘, 디에칠설페이드, 에칠아민 등)로 처리한 후 이 균현탄액을 배지중질소원으로서 알기닌 (1.5㎎/㎖)과 극히 소량의 유안(2-10㎍/㎖)을 첨가하여 평판배지(예를 들면 스빗츠엔 기초배지)에 2-3일간 배양한 후 코로니를 순수 분리하여 우량균주로 선택했다.This deficiency strain is a conventional mutation-inducing operation treated with, for example, X-ray irradiation, ultraviolet irradiation, or chemical variant organic matter (for example, N-methyl-N'-N nitrosoguanidine, diesulfide, ethylamine, etc.). Then, the bacteria suspension was incubated for 2-3 days in a plate medium (for example, Sbittzen basal medium) by adding arginine (1.5 mg / ml) and a very small amount of oil (2-10 µg / ml) as a medium nitrogen source. After the colony was purely separated and selected as a good strain.

본 발명의 알기닌탈탄산효소, 알기닌탈탄산산화효소 동시결손변이주 MS-05760(KFCC 10018)의 생리적 특성을 친주와 비교해 볼 때 친주와 당류 발효성이 전혀 다른 것이 발견되었다.When the physiological characteristics of the arginine decarboxylase and the arginine decarboxylase co-defective strain MS-05760 (KFCC 10018) of the present invention were compared with the parent strain, it was found that the parent strain and the sugar fermentability were completely different.

친주와 변이주의 당류발효성을 비교해 보면,Comparing the sugar fermentation of parental and mutant strains,

Figure kpo00001
Figure kpo00001

(주) 1. A : 산생성1.A: acid production

- : 산, 가스 공히 생성하지 않음.-: Does not generate acid or gas.

2. 발효배지 : 당을 함유한 펩톤배지(펩톤 1.0%, 염화나트륨 0.5%, 당 0.5-2.0%) 5cc 시험관에 정치, 30℃에서 8일간 배양.2. Fermentation broth: Peptone broth containing sugar (1.0% peptone, 0.5% sodium chloride, 0.5-2.0% sugar).

본 발명의 알기닌탈탄산효소, 알기닌탈탄산산화효소 동시결손 변이주인 브레비박테리움푸라붐 MS-05760(KFCC 10018)을 버기스메뉴얼(Bergey's Manual of Determinative Bacteriology) 및 미국 세균협회에서 발행한 미생물 실험서(Manual of Microbiological Method)에 따라 균학적 성질을 조사한 결과는 다음과 같았다.Microorganism experiment published by Bergy's Manual of Determinative Bacteriology and American Bacterial Association of Brevibacterium puraboom MS-05760 (KFCC 10018), which is a co-deleted variant of arginine decarboxylase and arginine decarboxylase of the present invention According to the Manual of Microbiological Method, the results were as follows.

가. 형태학적 성질end. Morphological properties

(1) 형태 : 단간균으로 0.7×1.0μ∼1.5×3.0μ(1) Form: Simple bacilli, 0.7 × 1.0μ ~ 1.5 × 3.0μ

(2) 운동성 : 없음(2) Mobility: None

(3) 그람염색 : 양성(3) Gram dyeing: positive

나. 생리학적 성질I. Physiological Properties

(1) 최적생육온도 : 28-32℃(1) Optimal growth temperature: 28-32 ℃

(2) 최적생육 pH : 6.8-7.2(2) Optimal growth pH: 6.8-7.2

(3) 산소요구성 : 호기성(3) Oxygen Requirements: Aerobic

(4) 유화수소생성 : 음성(4) hydrogen sulfide production: negative

(5) 제라틴액화력 : 없음, 표면에서 생육.(5) Gelatin liquefaction power: None, grow on the surface.

(6) 우레아제 : 양성(6) urease: positive

(7) 전분액화성 : 음성(7) Starch Liquefaction: Negative

(8) 카탈라제 : 양성(8) catalase: positive

다. 배양학적 성질All. Culture properties

1. 한천사면배양(육즙한천배지 28℃×30시간)1. Agar Slope Cultivation (Juicy Agar Medium 28 ℃ × 30 hours)

(1) 생육 : 보통(1) Growth: Normal

(2) 형상 : 버터상(2) Shape: Butter

(3) 광택 : 약광택(3) Gloss: Weak Gloss

(4) 균체색소 : 담황색(4) Cell color: light yellow

2. 한천평판배양(육즙한천배지 28℃×30시간)2. Agar plate culture (Juicy agar plate 28 ℃ × 30 hours)

(1) 생육 : 보통(1) Growth: Normal

(2) 형상 : 원형(2) Shape: Round

(3) 형태 : 반렌즈형(3) Shape: Semi-lens type

본 발명에 사용되는 변이주의 발효용 배지로서는 통상의 탄소원, 질소원, 무기염류 및 유기영양 물질을 함유하고 있는데 탄소원으로서는 포도당, 당밀, 전분가수분해물 등의 당질을 사용했다.The fermentation medium for the mutant strains used in the present invention contains a common carbon source, nitrogen source, inorganic salts, and organic nutrients. As the carbon source, sugars such as glucose, molasses, and starch hydrolyzate are used.

질소원으로서는 염화암모니움, 유산암모니움 등의 무기암모니움을 2-5% 사용했으며, 무기염류로는, 인산카리, 유산마그네슘, 유산철 등을 소량 첨가했으며 유기영양물질로는 펩톤, 효모에키스, 콘·스팁·리카 등을 0.01-2.0% 사용했다.As a nitrogen source, 2-5% of inorganic ammonium such as ammonium chloride and lactic acid ammonium was used. As inorganic salts, small amounts of potassium phosphate, magnesium lactate, and iron lactate were added. As organic nutrients, peptone and yeast ekis , Cone tip rica and the like were used at 0.01-2.0%.

발효방법은 온도 24-35℃, pH 6.0-8.0로 유지하면서 호기적으로 2-7일간 진탕 배양했다.The fermentation method was shaken for 2-7 days in aerobic conditions while maintaining the temperature of 24-35 ℃, pH 6.0-8.0.

축적된 L-알기닌의 채취는 통상이온교환수지와 그외의 공지의 방법을 조합했다.Collected L-arginine was combined with a conventional ion exchange resin and other known methods.

이때 L-알기닌 이외의 다른 아미노산의 생성은 극히 소량이였다.The production of amino acids other than L-arginine was extremely small.

L-알기닌의 확인은 페이퍼크로마토그라피에 의했으며, L-알기닌의 정량은 바이오에세이법에 의했다.L-arginine was identified by paper chromatography, and L-arginine was quantified by bioassay.

또한 알기닌탈탄산효소 및 알기닌탈탄산산화효소의 결손여부는 CO2발생을 검압적으로 측정했다.In addition, the deficiency of arginine decarboxylase and arginine decarboxylase was measured by CO 2 .

(E.F. Gale, Biochem. J.34,392(1940), E.S. Taylor, E.F. Gale, Biochem. J.39,52(1945))(EF Gale, Biochem. J. 34, 392 (1940), ES Taylor, EF Gale, Biochem. J. 39, 52 (1945))

[실시예 1]Example 1

당밀 5%, 염화암모니움 2.5%, 펩톤 0.1%, 효모에키스 0.1%, 제2인산카리 1.0%, 유산마그네슘 0.05%, 유산제1철 0.001%, 콘·스팁·리카1.5%, 유산망간 0.001%, 탄산칼슘 2%를 함유한 배지(pH 7.3)30㎖를 500㎖ 진탕후 라스크에 넣어 115℃에서 15분간 가압 멸균한다. 이때 당밀과 탄산칼슘은 별도로 살균하여 첨가한다. 이 배지에 브레비박테리움푸라붐 MS-05760(알기닌탈탄산효소, 알기닌탈탄산산화효소 동시결손주)(KFCC 10018)을 1백금이 접종한 후 30℃에서 65시간 진탕 배양한다.Molasses 5%, ammonium chloride 2.5%, peptone 0.1%, yeast ekis 0.1%, dibasic phosphate 1.0%, magnesium lactic acid 0.05%, ferrous lactic acid 0.001%, corn steep rika 1.5%, manganese 0.001 30 ml of medium (pH 7.3) containing% and 2% calcium carbonate was added to a 500 ml shaken flask and sterilized under pressure at 115 ° C. for 15 minutes. At this time, molasses and calcium carbonate are added by sterilization separately. This medium was inoculated with Brevibacterium puraboom MS-05760 (arginine decarboxylase and arginine decarboxylase) (KFCC 10018) after inoculation with platinum and incubated for 65 hours at 30 ° C.

배양액중의 L-알기닌의 생성량은 20.8㎎/㎖이며 동 방법시 친주의 경우는 2.46㎎/㎖이다.The amount of L-arginine produced in the culture was 20.8 mg / mL and 2.46 mg / mL in the case of parent strain.

[실시예 2]Example 2

실시예 1과 같은 배지 조성에 아스파라긴산 2.5%을 첨가하여 실시예 1의 균주인 브레비박테리움푸라붐 MS-05760(KFCC 10018)을 1백금이 접종한다.Platinum is inoculated with Brevibacteriumfuraboom MS-05760 (KFCC 10018), which is a strain of Example 1, by adding 2.5% aspartic acid to the same medium composition as in Example 1.

이하 실시예 1과 같은 방법으로 처리한 결과 배양액중 L-알기닌의 생성량은 21.3g이며, 동 방법시 친주의 경우는 2.57㎎/㎖이다.As a result of treatment in the same manner as in Example 1, the amount of L-arginine produced in the culture medium was 21.3 g, and in the case of the parent strain of the same method, 2.57 mg / ml.

[실시예 3]Example 3

실시예 1과 같은 배지조성에 L-글루타민산 2.0%를 첨가하여 실시예 1의 균주인 브레비박테리움푸라붐 MS-05760(알기닌탈탄산효소, 알기닌탈탄산산화효소 동시결손주)을 1백금이 접종한 후 30℃에서 72시간 배양한다. (130rpm) 이발효액 1ℓ을 가열한 후 여과한다. 이 액을 엠버라이트 IR-120B(H형) 칼람에 통한 후 수세 흡착후 L-알기닌을 5% 암모니아스로 용출한다. 분리된 L-알기닌을 감압농축하여 얻어진 잔사를 메타놀 및 염산으로 석출, 결정한다.L-glutamic acid 2.0% was added to the same medium composition as in Example 1, and the strain Brevibacteriumfuraboom MS-05760 (arginine decarboxylase, arginine decarboxylase) was simultaneously platinum. After inoculation, incubate at 30 ° C. for 72 hours. (130 rpm) 1 L of the fermentation broth is heated and filtered. This solution is passed through an Amberlite IR-120B (type H) column, followed by washing with water to elute L-arginine with 5% ammonia. The resulting L-arginine was concentrated under reduced pressure to precipitate and determine the residue with methanol and hydrochloric acid.

이 결정을 함수메타놀로 재결정한다.This crystal is recrystallized from hydrated methanol.

이때 L-알기닌염산염 23.6g을 얻었으며 동 방법시 친주의 경우 2.45g을 얻었다.At this time, 23.6 g of L-arginine hydrochloride was obtained, and 2.45 g of the parent strain was obtained in the same method.

[실시예 4]Example 4

포도당 3.0%, 요소 1.0%, 유산암모니움 0.5%, 콘·스팁·리카 0.7%, 제2인산카리 0.2%, 유산마그네슘 0.01%, 유산제1철 0.001%, 탄산칼슘 1.5%을 함유한 배지(pH 7.3) 30㎖을 500㎖ 진탕후 라스크에 넣어 120℃에서 10분간 가압 멸균한다. 이때 탄산칼슘은 별도로 살균하여 첨가한다.Medium containing glucose 3.0%, urea 1.0%, lactic acid ammonium 0.5%, corn steep lyca 0.7%, dibasic phosphate 0.2%, magnesium lactate 0.01%, ferrous lactate 0.001%, calcium carbonate 1.5% pH 7.3) 30 ml is put into a 500 ml shake and the flask is autoclaved at 120 ° C. for 10 minutes. At this time, calcium carbonate is added by sterilization separately.

이 배지에 브레비박테리움푸라붐 MS-05760(KFCC 10018)을 1백금이 접종한 후 30℃에서 72시간 진탕배양한다.This medium was inoculated with Brevibacterium puraboom MS-05760 (KFCC 10018) by platinum and shaken at 30 ° C for 72 hours.

배양액중의 L-알기닌의 생성량은 20.8㎎/㎖이였으며 동 방법시 친주의 경우는 2.16㎎/㎖였다.The amount of L-arginine produced in the culture was 20.8 mg / ml, and the parent strain of the method was 2.16 mg / ml.

Claims (1)

브레비박테리움 푸라붐 MS-05760(KFCC 10018)(알기닌탈탄산효소, 알기닌탈탄산산화효소 동시결손주)을 배양하여 배지중에 L-알기닌을 다량 생성 축척시켜 채취하는 것을 특징으로 하는 L-알기닌의 제조법.L-arginine, characterized by culturing Brevibacterium furaboom MS-05760 (KFCC 10018) (arginine decarboxylase, arginine decarboxylase co-deleted strain) and collecting and accumulating large amounts of L-arginine in the medium. Recipe.
KR1019800000353A 1980-01-31 1980-01-31 Process for preparation of l-alginine by fermentation KR810001114B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019800000353A KR810001114B1 (en) 1980-01-31 1980-01-31 Process for preparation of l-alginine by fermentation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019800000353A KR810001114B1 (en) 1980-01-31 1980-01-31 Process for preparation of l-alginine by fermentation

Publications (1)

Publication Number Publication Date
KR810001114B1 true KR810001114B1 (en) 1981-09-18

Family

ID=19215366

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800000353A KR810001114B1 (en) 1980-01-31 1980-01-31 Process for preparation of l-alginine by fermentation

Country Status (1)

Country Link
KR (1) KR810001114B1 (en)

Similar Documents

Publication Publication Date Title
KR960016135B1 (en) Process for producing l-isoleucine
JP3698758B2 (en) Method for producing L-leucine by fermentation
CA2090207C (en) Process for the production of amino acids by fermentation
EP0530803B1 (en) Process for producing L-threonine
CA1303536C (en) Process for producing l-threonine by fermentation
JP3966583B2 (en) Method for producing L-amino acid by fermentation
DE3139397A1 (en) METHOD FOR PRODUCING AMINO ACIDS ON A FERMENTATIVE WAY
US5250423A (en) Method for the production of L-lysine employing thermophilic corynebacterium thermoaminogenes
US2979439A (en) Method of producing l-lysine by fermentation
US4463094A (en) Fermentation production of L-threonine
JPS6257315B2 (en)
JP3717970B2 (en) Method for producing L-isoleucine by fermentation
US5460958A (en) Process for producing L-isoleucine by S-2-aminoethyl-L-cysteine or D-Serine resistant strains of E coli
JPH10248588A (en) Production of l-serine by fermentation
EP0205849B1 (en) Process for producing l-threonine by fermentation
US2978384A (en) Method for the production of 1-glutamic acid
FI86557B (en) FOERFARANDE FOER FRAMSTAELLNING AV ALFAAMYLAS MEDELST EN MICROORGANISM AV ARTEN BACILLUS SUBTILIS.
KR810001114B1 (en) Process for preparation of l-alginine by fermentation
Hagino et al. L-Lysine production by mutants of Bacillus licheniformis
EP0076516B1 (en) Method for fermentative production of l-proline
JPH119296A (en) Production of l-glutamic acid by fermentation process
KR920005749B1 (en) Method for producing l-arginine and new microorganism
EP0445830A2 (en) Process for producing L-threonine
JP3006907B2 (en) Method for producing L-alanine by fermentation method
KR0146493B1 (en) Process for producing l-alanine by fermentation